Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis.

Guoyun, Xuan; Dawei, Ding; Ning, Liu; Yinan, Hu; Fangfang, Yang; Siyuan, Tian; Hao, Sun; Jiaqi, Yang; Ang, Xu; Guanya, Guo; Xi, Chen; Yulong, Shang; Ying, Han

Guoyun, Xuan; Dawei, Ding; Ning, Liu; Yinan, Hu; Fangfang, Yang; Siyuan, Tian; Hao, Sun; Jiaqi, Yang; Ang, Xu; Guanya, Guo; Xi, Chen; Yulong, Shang; Ying, Han.

Affiliation

Guoyun X; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Dawei D; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Ning L; Medical Service, The Air Force Hospital of Southern Theater of PLA, Guangzhou, China.
Yinan H; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Fangfang Y; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Siyuan T; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Hao S; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Jiaqi Y; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Ang X; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Guanya G; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Xi C; Medical Service, The Air Force Hospital of Southern Theater of PLA, Guangzhou, China.
Yulong S; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Ying H; National Clinical Research Centre for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi'an, China.

Front Pharmacol ; 13: 948362, 2022.

Article de En | MEDLINE | ID: mdl-36110537

Mots clés

clinical trial; fenofibrate; meta-analysis; monotherapy; primary biliary cholangitis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline / Observational_studies / Systematic_reviews Langue: En Journal: Front Pharmacol Année: 2022 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google